NCT05808192View on ClinicalTrials.gov

De Novo Metabolic Syndrome in Liver Transplant Patients After Immunosuppression Withdrawal

CompletedOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

February 1, 2022

Study Completion Date

May 1, 2022

Conditions
Single Transplant5 Years of Follow-up After Transplant, in Which an Attempt Was Made to Suspend IS
Interventions
DRUG

Immunosuppressive

compare MS development in patients who achieve to suspend IS drugs after LT and in those who could not suspend.

Trial Locations (1)

00133

Roberta Angelico, Rome

All Listed Sponsors
lead

University of Rome Tor Vergata

OTHER

NCT05808192 - De Novo Metabolic Syndrome in Liver Transplant Patients After Immunosuppression Withdrawal | Biotech Hunter | Biotech Hunter